Skip to main content

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes.
Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer.
As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 11, Number 5, June 2011

Articles

Favourites:
ADD

A Cross-Talk Between NFAT and NF-κB Pathways is Crucial for Nickel- Induced COX-2 Expression in Beas-2B Cells
pp. 548-559(12)
Authors: Cai, T.; Li, X.; Ding, J.; Luo, W.; Li, J.; Huang, C.

Favourites:
ADD

Targeting Aldose Reductase for the Treatment of Cancer
pp. 560-571(12)
Authors: Tammali, R.; K. Srivastava, S.; V. Ramana, K.

Favourites:
ADD

CD44-Targeting for Antitumor Drug Delivery: A New SN-38-Hyaluronan Bioconjugate for Locoregional Treatment of Peritoneal Carcinomatosis
pp. 572-585(14)
Authors: Serafino, A.; Zonfrillo, M.; Andreola, F.; Psaila, R.; Mercuri, L.; Moroni, N.; Renier, D.; Campisi, M.; Secchieri, C.; Pierimarchi, P.

Favourites:
ADD
Favourites:
ADD

The Centrosome: A Target for Cancer Therapy
pp. 600-612(13)
Authors: Mazzorana, M.; Montoya, G.; B. Mortuza, G.

Favourites:
ADD

Drug Resistance: Challenges to Effective Therapy
pp. 613-623(11)
Author: P.V. Shekhar, M.

Favourites:
ADD

VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
pp. 624-653(30)
Authors: S. Sharma, P.; Sharma, R.; Tyagi, T.

Favourites:
ADD

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more